Details of the Drug
General Information of Drug (ID: DMWJN73)
| Drug Name |
4-(Hydroxymercury)Benzoic Acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
p-hydroxymercuribenzoic acid; p-hydroxymercuribenzoate; (p-carboxyphenyl)hydroxymercury; 4-(HYDROXYMERCURY)BENZOIC ACID; mercury, (p-carboxyphenyl)hydroxy-; (4-carboxyphenyl)(hydroxy)mercury; (4-carboxylatophenyl)hydroxymercurate(1-) hydrogen; 1126-48-3; Sodium p-chloromercuribenzoate; Mercury, sodium salt; Mercury, monosodium salt; Mercurate(1-), sodium; SCHEMBL678164; CHEMBL78771; Mercurate(1-), (4-carboxylatophenyl)hydroxy-, hydrogen; CHEBI:49644; NSC1048; NSC-1048
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 339.72 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() Drug Off-Target (DOT) |
|
||||||||||||||||||||||||||
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||



